Endovia Health Sciences Receives FDA Regulatory Milestone for CannEpil Veterinary Program
Endovia Health Sciences, formerly Splash Beverage, received Investigational New Animal Drug (INAD) status for its veterinary cancer pain treatment CannEpil, marking its first regulatory milestone under the Lupvindol collaboration.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day